RecruitingNot ApplicableNCT06590285

Diagnostic Refinement and Educational Approaches in Managing Bone Marrow Transplantation

Diagnostic Refinement and Educational Approaches in Managing Bone Marrow Transplantation (DREAM-BMT)


Sponsor

Scripps Health

Enrollment

60 participants

Start Date

Apr 2, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

This randomized, phase I/II, open-label study will investigate the efficacy and safety of an educational sleep intervention vs standard of care in adults undergoing alloHSCT. The randomization target in this pilot phase is 60 patients.


Eligibility

Min Age: 18 Years

Inclusion Criteria4

  • Male or female patients aged 18 or older at the time of study informed consent.
  • Have plan to undergo alloHSCT from any donor source using bone marrow, peripheral blood stem cells, or cord blood. Recipients of non-myeloablative, myeloablative and reduced intensity conditioning are eligible.
  • Patients have access to digital device capable of downloading study app
  • Patients able to read study documents and able to complete informed consent within the study app

Exclusion Criteria1

  • Failed prior alloHSCT within the past 6 months

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALApp-based Educational Intervention

The program's educational content is designed to engage patients in the science of sleep and recovery. Segments like "The Sleep Adventure" demystify complex neurobiological processes in an accessible format, aligning with emerging trends in patient education that focus on engagement and knowledge empowerment. Concurrently, the program's physical activity component is meticulously crafted, offering safe, supportive exercises that correspond with the treatment stages of alloHSCT patients. This aspect draws upon evidence highlighting the importance of sustained physical activity during intensive treatments to enhance overall recovery and quality of life. Additionally, the program comprehensively addresses sleep disturbances, prevalent in HSCT patients, through in-depth exploration and evidence-based, non-pharmacologic management strategies, reflecting the significant impact of sleep quality on patient recovery and long-term health outcomes.


Locations(1)

Scripps Health

San Diego, California, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06590285


Related Trials